%0 Journal Article
%T A crisis in clinical research.
%A Hong DS
%A LoRusso P
%A Sznol M
%J J Immunother Cancer
%V 12
%N 7
%D 2024 Jul 11
%M 38991727
%F 12.469
%R 10.1136/jitc-2023-008520
%X The clinical research pipeline is critical to ensuring continued development of novel treatments that can offer patients with cancer safe and effective options. Unfortunately, progress has slowed since the COVID-19 pandemic due to uncovered, systemic inefficiencies across critical processes. Towards initiating discussion on how to reinvigorate clinical research, the Society for Immunotherapy of Cancer (SITC) hosted a virtual summit that characterized issues and formed potential solutions. This commentary serves to highlight the crisis facing clinical research as well as stimulate field-wide discussion on how to better serve patients into the future.